Lenvervimab Explained

Type:	mab
Source:	zu
Target:	hepatitis B virus surface antigen
Cas Number:	2055006-79-4
Atc Prefix:	none
Unii:	FX9X4L2A2L
Synonyms:	GC1102

Lenvervimab (INN;^[1] development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B.^[2]

This drug is being developed by GC Pharma., lenvervimab is undergoing Phase II/III trials.

Notes and References

1. . International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 118 . WHO Drug Information . 31 . 4 . 2017 .
2. Jeong GU, Ahn BY, Jung J, Kim H, Kim TH, Kim W, Lee A, Lee K, Kim JH . A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants . PLOS ONE . 15 . 8 . e0236704 . 2020 . 32790777 . 7425877 . 10.1371/journal.pone.0236704 . 2020PLoSO..1536704J . free .